Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Newmont (NEMCL) Current Assets (2016 - 2025)

Newmont has reported Current Assets over the past 17 years, most recently at $13.1 billion for Q4 2025.

  • Quarterly results put Current Assets at $13.1 billion for Q4 2025, up 6.44% from a year ago — trailing twelve months through Dec 2025 was $13.1 billion (up 6.44% YoY), and the annual figure for FY2025 was $13.1 billion, up 6.44%.
  • Current Assets for Q4 2025 was $13.1 billion at Newmont, up from $10.4 billion in the prior quarter.
  • Over the last five years, Current Assets for NEMCL hit a ceiling of $13.1 billion in Q4 2025 and a floor of $6.0 billion in Q3 2023.
  • Median Current Assets over the past 5 years was $7.6 billion (2021), compared with a mean of $8.9 billion.
  • Biggest five-year swings in Current Assets: soared 111.2% in 2024 and later dropped 17.53% in 2025.
  • Newmont's Current Assets stood at $7.7 billion in 2021, then decreased by 15.35% to $6.5 billion in 2022, then increased by 15.3% to $7.5 billion in 2023, then soared by 63.41% to $12.3 billion in 2024, then grew by 6.44% to $13.1 billion in 2025.
  • The last three reported values for Current Assets were $13.1 billion (Q4 2025), $10.4 billion (Q3 2025), and $10.4 billion (Q2 2025) per Business Quant data.